Lawrence Stennett

1.7k total citations
10 papers, 695 citations indexed

About

Lawrence Stennett is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lawrence Stennett has authored 10 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Lawrence Stennett's work include Chronic Lymphocytic Leukemia Research (3 papers), melanin and skin pigmentation (3 papers) and Cancer-related Molecular Pathways (3 papers). Lawrence Stennett is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), melanin and skin pigmentation (3 papers) and Cancer-related Molecular Pathways (3 papers). Lawrence Stennett collaborates with scholars based in United States, South Korea and Spain. Lawrence Stennett's co-authors include Brian J. Nickoloff, Vijaya Chaturvedi, Frank Bennett, Mary J.C. Hendrix, Barbara Bodner, Pamela M. Pollock, Lucio Miele, Jian‐Zhong Qin, Jeffrey M. Trent and Brian K. Bonish and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Lawrence Stennett

10 papers receiving 690 citations

Peers

Countries citing papers authored by Lawrence Stennett

Since Specialization

Citations

This map shows the geographic impact of Lawrence Stennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Stennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Stennett more than expected).

Fields of papers citing papers by Lawrence Stennett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Stennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Stennett. The network helps show where Lawrence Stennett may publish in the future.

Co-authorship network of co-authors of Lawrence Stennett

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Stennett. A scholar is included among the top collaborators of Lawrence Stennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Stennett. Lawrence Stennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	ON 01910.Na Is Selectively Cytotoxic for Chronic Lymphocytic Leukemia Cells through a Dual Mechanism of Action Involving PI3K/AKT Inhibition and Induction of Oxidative Stress 2012 ·Clinical Cancer Research ·(unknown), Ellen X. Sun, Mark Roschewski, Georg Aue, (unknown), Lawrence Stennett, Federica Gibellini, Diane C. Arthur, Patricia Pérez‐Galán, Adrian Wiestner	61
2	Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation 2010 ·Blood ·Patricia Pérez‐Galán, Helena Mora-Jensen, Marc A. Weniger, Arthur L. Shaffer, Edgar Gil Rizzatti, (unknown), Clifton C. Mo, Lawrence Stennett, Christoph Rader, Poching Liu, Nalini Raghavachari, Maryalice Stetler‐Stevenson, Constance M. Yuan, Stefania Pittaluga, Irina Marić, Kieron Dunleavy, Wyndham H. Wilson, Louis M. Staudt, Adrian Wiestner	90
3	Loss of CD20 Expression and Exhaustion of Effector Cells Limit ADCC in CLL Patients Treated with Rituximab. 2009 ·Blood ·Bérengère Vire, (unknown), Elinor Lee, Lawrence Stennett, Leigh Samsel, Philip McCoy, Wyndham H. Wilson, Bibiana Bielekova, Adrian Wiestner	2
4	Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma Cells 2005 ·Cancer Research ·Jian‐Zhong Qin, (unknown), Lawrence Stennett, Barbara Bodner, Brian K. Bonish, Vijaya Chaturvedi, Frank Bennett, Pamela M. Pollock, Jeffrey M. Trent, Mary J.C. Hendrix, Paola Rizzo, Lucio Miele, Brian J. Nickoloff	263
5	Expression of gp100 and CDK2 in Melanoma Cells is not Co‐Regulated by a Shared Promoter Region 2004 ·Pigment Cell Research ·Lawrence Stennett, Adam I. Riker, (unknown), (unknown), Toru Miki, Brian J. Nickoloff, I. Caroline Le Poole	7
6	p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas 2004 ·Molecular Cancer Therapeutics ·Jian‐Zhong Qin, Lawrence Stennett, Patricia Bacon, Barbara Bodner, Mary J.C. Hendrix, Richard E.B. Seftor, Elisabeth A. Seftor, Naira V. Margaryan, Pamela M. Pollock, (unknown), Jeffrey M. Trent, Frank Bennett, Lucio Miele, Brian J. Nickoloff	106
7	Resistance to UV‐induced apoptosis in human keratinocytes during accelerated senescence is associated with functional inactivation of p53 2003 ·Journal of Cellular Physiology ·Vijaya Chaturvedi, (unknown), Lawrence Stennett, Vinay Choubey, B J Nickoloff	44
8	Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin 2003 ·British Journal of Dermatology ·I. Caroline Le Poole, Lawrence Stennett, Brian K. Bonish, (unknown), June K. Robinson, Claudia Hernandez, (unknown), B J Nickoloff	26
9	Interferon-γ Reduces Melanosomal Antigen Expression and Recognition of Melanoma Cells by Cytotoxic T Cells 2002 ·American Journal Of Pathology ·I. Caroline Le Poole, Adam I. Riker, (unknown), Lawrence Stennett, Ena Wang, Francesco M. Marincola, W. Martin Kast, June K. Robinson, Brian J. Nickoloff	43
10	‘VIT1’, A Novel Gene Associated with Vitiligo 2001 ·Pigment Cell Research ·I. Caroline Le Poole, Rangaprasad Sarangarajan, Yang Zhao, Lawrence Stennett, Thomas L. Brown, Pranav Sheth, Toru Miki, Raymond E. Boissy	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact